Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
President, International AIDS Society
Dean, Faculty of Medicine
Professor of Medicine and Infectious Diseases
University of Malaya
Kuala Lumpur, Malaysia
Adjunct Associate Professor of Medicine
New Haven, Connecticut
Adeeba Kamarulzaman, MBBS, FRACP, FASc, has no disclosures to report within the past 24 months. She discloses that she has previously received financial or material support from Sanofi and consulting fees from Zuellig-Pharma.
In the 40 years since the first reported cases of AIDS, nearly 35 million people have died from AIDS-related causes.
Today, thanks to scientific inquiry, a positive HIV test no longer means fear and despair. A mother with HIV can give birth without passing it on to her child, and an undetectable viral load is untransmittable between partners. Each year, our treatment and prevention efforts improve. And each year, we continue to unlock the mysteries of how HIV interacts with the human body.
Beginning July 18, the International AIDS Society (IAS) will host the first virtual convening of the IAS Conference on HIV Science, as another pandemic prevents many of us from meeting in-person to share the latest breakthroughs in science, medicine, health policy, and program implementation.
Despite the challenges of COVID-19 lockdowns, curfews, and supply disruptions, we have planned a robust scientific program. Highlights include advancements in the search for an HIV cure, analysis of the impact of COVID-19 on the global HIV response, and the specific obstacles faced by women and girls.
Key highlights to expect at the 11th IAS Conference on HIV Science (IAS 2021) include the following:
Another theme emerging from the science is innovative new tools. Studies examining the safety and effectiveness of new technology include the following:
We are thrilled to see that HIV research has not been completely brushed aside during the COVID-19 pandemic. Just as 40 years of HIV experience informed the COVID-19 response, the scientific breakthroughs and political will achieved in that response must now propel our efforts to end HIV.
Our focus as we head into IAS 2021 is to keep this momentum going. We now have new opportunities to adapt and enhance COVID-19 approaches and sustain global attention and commitment to prioritizing public health. We hope you will attend the conference and put important new data in HIV science to work in your practice.